May 6, 2014
The latest news from the UW Health Sciences and UW Medicine: What price for a cure? The economics of drug pricing The uproar against the $1,000-a-pill hepatitis C drug Sovaldi, generic name sofosbuvir, may signal a turning point in drug pricing in the United States. Purchasers appear to be pushing back and saying, “No.”
March 21, 2014
The official announcement of the results of the National Residency Matching Program is an annual rite of passage for UW medical students and their peers across the United States. The wait is over.
February 10, 2014
People who are genetically equipped to stop hepatitis C viruses from turning off a type of interferon generally have a robust antiviral response. Findings on the mechanisms governing this ability suggest new avenues for treatment research.
January 29, 2014
A fossil-free method of sequencing archaic DNA may provide insight into human evolution.
January 13, 2014
The national, decade-long ACTIVE study showed that cognitive training can help the elderly maintain certain thinking and reasoning skills useful in everyday life.
December 26, 2013
Clark was recognized for his work in the neurobiology of motivated behavior. His award will support investigations of how alcohol exposure during the teen years might lead to chronic alcoholism in adults.
December 19, 2013
Cell surface lipids hide molecular patterns that infection-killing cells might recognize as dangerous.
November 24, 2013
Filtered from a vast sodium sea, more than 1 million calcium ions per second gush through our cells’ pores to generate charges
November 14, 2013
Rapamycin, an anti-rejection drug for organ transplant patients, has now been shown to increases survival in and delayed symptoms of Leigh’s syndrome. The drug appears to cause a metabolic switch that bypasses the mitochondrial deficiency.
November 7, 2013
The method may help overcome a major obstacle that has delayed progress in designing rapid, low-cost — but still accurate — ways to assemble genomes from scratch. It also may validate certain types of chromosomal abnormalities in cancer.« Previous Page Next Page »